Conjunctival Hyperemia
📧 Sign up to get email alerts when something new happens for Conjunctival Hyperemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Conformity of Conjunctival Hyperemia Assessment in Soft Contact Lens Wearers Using Image J Analysis and Efron Degree System [NA]
This completed clinical trial update evaluates the conformity of a conjunctival hyperemia assessment in soft contact lens wearers using Imag…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Safety and Tolerability of PRO-185 [Phase 1]
Phase 1 safety and tolerability study of PRO-185 for conjunctival hyperemia completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: "Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness" [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a preservative-free brimonidine tartrate formulation for ocular redness in adults has …
-
FDA approval · 2024-04-19FDA Approved: LUMIFY PRESERVATIVE FREE EYE DROPS — Original Application (Bausch & Lomb Incorporated)
The FDA approved the original NDA for Lumify Preservative Free Eye Drops (brimonidine tartrate) by Bausch & Lomb, a preservative-free formul…
-
FDA approval · 2024-02-28FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental NDA for LUMIFY redness reliever eye drops (brimonidine tartrate) from Bausch & Lomb, enabling continued mark…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-05-02FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for Lumify redness-relief eye drops (brimonidine tartrate) from Bausch & Lomb, updating the labe…
-
FDA approval · 2021-11-29FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Lumify Redness Reliever Eye Drops (brimonidine tartrate) by Bausch & Lomb, expanding labeling to…
-
FDA approval · 2020-09-23FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for Lumify redness reliever eye drops (brimonidine tartrate) from Bausch & Lomb Incorporated.
-
FDA approval · 2019-04-30FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for LUMIFY Redness Reliever Eye Drops (brimonidine tartrate) from Bausch & Lomb Incorporated. The pr…
-
FDA approval · 2019-02-21FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Supplemental Application (Bausch & Lomb Incorporated)
FDA approves a supplemental application for Lumify redness reliever eye drops (brimonidine tartrate) from Bausch & Lomb. The action expands …
-
FDA approval · 2017-12-22FDA Approved: LUMIFY REDNESS RELIEVER EYE DROPS — Original Application (Bausch & Lomb Incorporated)
FDA approved Lumify redness reliever eye drops (brimonidine tartrate) via an Original Application for the temporary relief of eye redness du…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%. [Phase 1]
Phase 1 trial evaluated the pharmacokinetics and safety of brimonidine tartrate 0.025% ophthalmic solution for ocular hyperemia; the study i…